Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology

Alzheimer’s disease (AD) is an incurable neurodegenerative disorder in which dysfunction and loss of synapses and neurons lead to cognitive impairment and death. Accumulation and aggregation of neurotoxic amyloid-β (Aβ) peptides generated via amyloidogenic processing of amyloid precursor protein (AP...

Full description

Bibliographic Details
Main Authors: Grant Pfundstein, Alexander G. Nikonenko, Vladimir Sytnyk
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.969547/full
_version_ 1818161147600175104
author Grant Pfundstein
Alexander G. Nikonenko
Vladimir Sytnyk
author_facet Grant Pfundstein
Alexander G. Nikonenko
Vladimir Sytnyk
author_sort Grant Pfundstein
collection DOAJ
description Alzheimer’s disease (AD) is an incurable neurodegenerative disorder in which dysfunction and loss of synapses and neurons lead to cognitive impairment and death. Accumulation and aggregation of neurotoxic amyloid-β (Aβ) peptides generated via amyloidogenic processing of amyloid precursor protein (APP) is considered to play a central role in the disease etiology. APP interacts with cell adhesion molecules, which influence the normal physiological functions of APP, its amyloidogenic and non-amyloidogenic processing, and formation of Aβ aggregates. These cell surface glycoproteins also mediate attachment of Aβ to the neuronal cell surface and induce intracellular signaling contributing to Aβ toxicity. In this review, we discuss the current knowledge surrounding the interactions of cell adhesion molecules with APP and Aβ and analyze the evidence of the critical role these proteins play in regulating the processing and physiological function of APP as well as Aβ toxicity. This is a necessary piece of the complex AD puzzle, which we should understand in order to develop safe and effective therapeutic interventions for AD.
first_indexed 2024-12-11T16:13:09Z
format Article
id doaj.art-2123f68107b744559a56de68854b1867
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-11T16:13:09Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-2123f68107b744559a56de68854b18672022-12-22T00:59:00ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-07-011010.3389/fcell.2022.969547969547Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiologyGrant Pfundstein0Alexander G. Nikonenko1Vladimir Sytnyk2School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, AustraliaDepartment of Cytology, Bogomoletz Institute of Physiology, Kyiv, UkraineSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, AustraliaAlzheimer’s disease (AD) is an incurable neurodegenerative disorder in which dysfunction and loss of synapses and neurons lead to cognitive impairment and death. Accumulation and aggregation of neurotoxic amyloid-β (Aβ) peptides generated via amyloidogenic processing of amyloid precursor protein (APP) is considered to play a central role in the disease etiology. APP interacts with cell adhesion molecules, which influence the normal physiological functions of APP, its amyloidogenic and non-amyloidogenic processing, and formation of Aβ aggregates. These cell surface glycoproteins also mediate attachment of Aβ to the neuronal cell surface and induce intracellular signaling contributing to Aβ toxicity. In this review, we discuss the current knowledge surrounding the interactions of cell adhesion molecules with APP and Aβ and analyze the evidence of the critical role these proteins play in regulating the processing and physiological function of APP as well as Aβ toxicity. This is a necessary piece of the complex AD puzzle, which we should understand in order to develop safe and effective therapeutic interventions for AD.https://www.frontiersin.org/articles/10.3389/fcell.2022.969547/fullcell adhesion molecule (CAM)Alzheimer’s diseaseamyloid precursor protein (APP)amyloid-betaimmunoglobulin superfamilyintegrin
spellingShingle Grant Pfundstein
Alexander G. Nikonenko
Vladimir Sytnyk
Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
Frontiers in Cell and Developmental Biology
cell adhesion molecule (CAM)
Alzheimer’s disease
amyloid precursor protein (APP)
amyloid-beta
immunoglobulin superfamily
integrin
title Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
title_full Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
title_fullStr Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
title_full_unstemmed Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
title_short Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
title_sort amyloid precursor protein app and amyloid β aβ interact with cell adhesion molecules implications in alzheimer s disease and normal physiology
topic cell adhesion molecule (CAM)
Alzheimer’s disease
amyloid precursor protein (APP)
amyloid-beta
immunoglobulin superfamily
integrin
url https://www.frontiersin.org/articles/10.3389/fcell.2022.969547/full
work_keys_str_mv AT grantpfundstein amyloidprecursorproteinappandamyloidbabinteractwithcelladhesionmoleculesimplicationsinalzheimersdiseaseandnormalphysiology
AT alexandergnikonenko amyloidprecursorproteinappandamyloidbabinteractwithcelladhesionmoleculesimplicationsinalzheimersdiseaseandnormalphysiology
AT vladimirsytnyk amyloidprecursorproteinappandamyloidbabinteractwithcelladhesionmoleculesimplicationsinalzheimersdiseaseandnormalphysiology